Radiation-chemotherapy for head and neck cancer;Radiochemotherapie bei HNO-Tumoren

Strahlentherapie und Onkologie

Volumn 176, Issue 11, 2000, Pages 537-538

  Munker, R ^a   Reitmeier, M ^a   Hartenstein, R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NEUTROPENIA; NOTE; PATIENT COMPLIANCE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0033757189     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Simultaneous chemoradiotherapy with 5-FU/folinic acid/cis-platinum and accelerated split-course radiation in advanced head and neck cancer
2. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
3. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
4. Chemotherapy added to local treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. MACH-NC collaborative group
5. Comcomitant chemoradiotherapy as primary therapy for locally advanced head and neck cancer
6. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study